Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(00)00444-5 ◽

2001 ◽

Vol 37 (5) ◽

pp. 597-604 ◽

Author(s):

C Twelves ◽

M Boyer ◽

M Findlay ◽

J Cassidy ◽

C Weitzel ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Resource Use ◽

Phase Iii ◽

Medical Resource ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma

Download Full-text

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial

Annals of Oncology ◽

10.1023/a:1008270916325 ◽

1998 ◽

Vol 9 (5) ◽

pp. 535-541 ◽

Author(s):

M.M. Borner ◽

M. Castiglione ◽

M. Bacchi ◽

W. Weber ◽

R. Herrmann ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Low Dose ◽

Phase Iii ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma ◽

Download Full-text

Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3546 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3546-3546

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

T. Seufferlein ◽

P. Reichardt ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Safety Analysis ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma ◽

First Line Treatment

Download Full-text

Capecitabine reduces medical resource use for advanced colorectal carcinoma compared with 5-fluorouracil plus leucovorin

Evidence-based Oncology ◽

10.1054/ebon.2001.0163 ◽

2001 ◽

Vol 2 (4) ◽

pp. 224-226

Author(s):

Mark Vincent

Keyword(s):

Colorectal Carcinoma ◽

Resource Use ◽

Medical Resource ◽

Advanced Colorectal Carcinoma

Download Full-text

Medical resource use in a phase III trial (SO 14796) of XelodaTM (capecitabine) in previously untreated advanced/metastatic colorectal cancer

European Journal of Cancer ◽

10.1016/s0959-8049(99)80640-6 ◽

1999 ◽

Vol 35 ◽

pp. S68-S69 ◽

Author(s):

C. Twelves ◽

E. Van Cutsem ◽

K. Hieke ◽

C. Barker ◽

C. Jamieson ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Resource Use ◽

Phase Iii ◽

Medical Resource ◽

Phase Iii Trial

Download Full-text

Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3546 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3546-3546 ◽

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

T. Seufferlein ◽

P. Reichardt ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Safety Analysis ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma ◽

First Line Treatment

Download Full-text

Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of advanced colorectal carcinoma (ACRC): results of an interim safety analysis

Zeitschrift für Gastroenterologie ◽

10.1055/s-2004-831656 ◽

2004 ◽

Vol 42 (08) ◽

Author(s):

HT Arkenau ◽

HJ Schmoll ◽

S Kubicka ◽

T Seufferlein ◽

P Reichardt ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Safety Analysis ◽

Phase Iii ◽

Line Treatment ◽

Phase Iii Trial ◽

Advanced Colorectal Carcinoma ◽

First Line Treatment

Download Full-text

Baseline carcinoembryonic antigen as a predictive factor of ramucirumab efficacy in RAISE, a second-line metastatic colorectal carcinoma phase III trial

European Journal of Cancer ◽

10.1016/j.ejca.2017.03.007 ◽

2017 ◽

Vol 78 ◽

pp. 61-69 ◽

Author(s):

Takayuki Yoshino ◽

Radka Obermannová ◽

György Bodoky ◽

Rocio Garcia-Carbonero ◽

Tudor Ciuleanu ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Carcinoembryonic Antigen ◽

Predictive Factor ◽

Phase Iii ◽

Second Line ◽

Metastatic Colorectal Carcinoma ◽

Phase Iii Trial

Download Full-text

Feasibility Report of a Randomized Multicenter Controlled Phase III Trial of Adjuvant UFT/LV Therapy after Resection for Liver Metastasis from Colorectal Carcinoma

Annals of Oncology ◽

10.1016/s0923-7534(20)33095-7 ◽

2012 ◽

Vol 23 ◽

pp. ix211-ix212

Author(s):

J. Yamamoto ◽

K. Hatsuse ◽

N. Kokudo ◽

M. Oba ◽

T. Takayama ◽

...

Keyword(s):

Liver Metastasis ◽

Colorectal Carcinoma ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

3044 POSTER Capecitabine or Folinic acid/Fluorouracil i.v. bolus plus Eloxatin evaluation (COFFE trial) in metastatic colorectal carcinoma (MCRC): final results of the Southern Italy Cooperative Oncology Group (SICOG) phase III trial 0401

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70972-2 ◽

2007 ◽

Vol 5 (4) ◽

pp. 248-249 ◽

Author(s):

P. Comella ◽

B. Massidda ◽

G. Filippelli ◽

A. Farris ◽

D. Natale ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Southern Italy ◽

Phase Iii ◽

Oncology Group ◽

Metastatic Colorectal Carcinoma ◽

Phase Iii Trial

Download Full-text

Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial

Annals of Oncology ◽

10.1093/annonc/mdi185 ◽

2005 ◽

Vol 16 (6) ◽

pp. 878-886 ◽

Author(s):

P. Comella ◽

B. Massidda ◽

G. Filippelli ◽

S. Palmeri ◽

D. Natale ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Southern Italy ◽

Phase Iii ◽

High Dose ◽

Oncology Group ◽

Metastatic Colorectal Carcinoma ◽

Phase Iii Trial

Download Full-text